Skip to content

Efficacy of enteral nutrition with commercial formula and Taurine Supplementation on Clinical outcome and nutritional status of Critically Ill burned patients in burned intensive care unit

Efficacy of enteral nutrition with commercial formula and Taurine Supplementation on Clinical outcome and nutritional status of Critically ill burned patients in burned intensive care unit

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201307082017N13
Enrollment
45
Registered
2014-03-17
Start date
2013-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

burn. Burn of second degree, body region unspecified, Burn of third degree, body region unspecified

Interventions

Intervention 1: Hospital routine Nutrition (Control Group). Intervention 2: (Intervention Group1) energy requirement is calculated by harris benedict equation, enteral nutrition starts with 25ml/h ent
Treatment - Other
Hospital routine Nutrition (Control Group)
(Intervention Group1) energy requirement is calculated by harris benedict equation, enteral nutrition starts with 25ml/h enteral standard formula and increases to goal. Duration of intervention is ten
Intervention Group 2: energy requirement is calculated by harris benedict equation, enteral nutrition starts with 25ml/h standard enteral formula and increases to goal. 50 mg/kg BW.day of Taurine is g

Sponsors

Research Center of Infectious and Tropical Diseases, Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Burned patients between the age18 and 85 years with total body surface area of burn more 20%; enteral feeding requirement of at least 48 h and expected length of >48h stay in the ICU; patients without hepatic failure; renal failure; inborn errors of amino-acid metabolism; metabolic acidosis(pH less7.35); absolute contraindication to enteral nutrition; non pregnant woman. Exclusion criteria: patients who died before the end of intervention; patients unable to tolerate enteral feeding.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Clinical outcome measurement. Timepoint: day 1,3,6,9. Method of measurement: Sequential Organ Failure Assessment(SOFA) score.

Secondary

MeasureTime frame
Effect on Immune System. Timepoint: Baseline and end of intervention. Method of measurement: TNF-alpha(ELISA test), Interleukin 10(IL-10)(ELISA test), High sensitivity C reactive protein( hs-CRP)(ELISA test).;Effect on Nutritional Status. Timepoint: Baseline and end of intervention. Method of measurement: Prealbumin (Immunoturbidometric assay).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSima lak

Faculty of Nutrition, Tabriz University of Medical Sciences

lak_sima@yahoo.com+98 41 1335 7580

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026